Chronic ethanol consumption decreases serum sulfatide levels by suppressing hepatic cerebroside sulfotransferase expression in mice

Archives of Toxicology

Volumn 88, Issue 2, 2014, Pages 367-379

  Kanbe, Hiroki ^a,b   Kamijo, Yuji ^a,c   Nakajima, Takero ^a   Tanaka, Naoki ^a,d   Sugiyama, Eiko ^a,e   Wang, Lixuan ^f   Fang, Zhong Ze ^d   Hara, Atsushi ^a   Gonzalez, Frank J ^d   Aoyama, Toshifumi ^a  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KISSEI PHARMACEUTICAL CO LTD   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NATIONAL CANCER INSTITUTE   (United States)

^e Nagano Prefectural College   (Japan)

^f HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Cardiovascular disease; Cerebroside sulfotransferase; Ethanol; Oxidative stress; Sulfatide; Tissue factor

Indexed keywords

ALCOHOLISM; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; FEMALE; GANGLIOSIDE GALACTOSYLTRANSFERASE; LIPID METABOLISM; LIVER; MICE; MICE, INBRED STRAINS; OXIDATIVE STRESS; SULFOGLYCOSPHINGOLIPIDS; SULFOTRANSFERASES; THROMBOPLASTIN;

EID: 84893923965     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-013-1132-3     Document Type: Article

References (53)

1. Aoyama T, Yamano S, Waxman DJ, Lapenson DP, Meyer UA, Fischer V, Tyndale R, Inaba T, Kalow W, Gelboin HV (1989) Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. J Biol Chem 264:10388-10395
2. Aoyama T, Ueno I, Kamijo T, Hashimoto T (1994) Rat very-long-chain acyl-CoA dehydrogenase, a novel mitochondrial acyl-CoA dehydrogenase gene-product, is a rate-limiting enzyme in long-chain fatty-acid beta-oxidation system - cDNA and deduced amino amino-acid-sequence and distinct specificities of the cDNA-expressed protein. J Biol Chem 269:19088-19094
3. Aoyama T, Souri M, Ushikubo S, Kamijo T, Yamaguchi S, Kelley RI, Rhead WJ, Uetake K, Tanaka K, Hashimoto T (1995) Purification of human very-long-chain acyl-coenzyme A dehydrogenase and characterization of its deficiency in seven patients. J Clin Invest 95:2465-2473
4. Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, Gonzalez FJ (1998) Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα). J Biol Chem 273:5678-5684
5. Bertola A, Mathews S, Ki SH, Wang H, Gao B (2013) Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat Protoc 8:627-637
6. Brinton EA (2012) Effects of ethanol intake on lipoproteins. Curr Atheroscler Rep 14:108-114
7. Carmiel-Haggai M, Cederbaum AI, Nieto N (2003) Binge ethanol exposure increases liver injury in obese rats. Gastroenterology 125:1818-1833
8. Carr TP, Andresen CJ, Rudel LL (1993) Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin Biochem 26:39-42
9. Carson EJ, Pruett SB (1996) Development and characterization of a binge drinking model in mice for evaluation of immunological effects of ethanol. Alcohol Clin Exp Res 20:132-138
10. Cederholm A, Frostegård J (2007) Annexin A5 as a novel player in prevention of atherothrombosis in SLE and in the general population. Ann N Y Acad Sci 1108:96-103
11. Djoussé L, Gaziano JM (2008) Alcohol consumption and heart failure: a systematic review. Curr Atheroscler Rep 10:117-120
12. Dohi Y, Ikura T, Hoshikawa Y, Katoh Y, Ota K, Nakanome A, Muto A, Omura S, Ohta T, Ito A, Yoshida M, Noda T, Igarashi K (2008) Bach1 inhibits oxidative stress-induced cellular senescence by impeding p53 function on chromatin. Nat Struct Mol Biol 15:1246-1254
13. Furuta S, Hayashi H, Hijikata M, Miyazawa S, Osumi T, Hashimoto T (1986) Complete nucleotide sequence of cDNA and deduced amino acid sequence of rat liver catalase. Proc Natl Acad Sci USA 83:313-317
14. Gaziano JM, Gaziano TA, Glynn RJ, Sesso HD, Ajani UA, Stampfer MJ, Manson JE, Hennekens CH, Buring JE (2000) Light-to-moderate alcohol consumption and mortality in the Physicians' Health Study enrollment cohort. J Am Coll Cardiol 35:96-105
15. Guo R, Ren J (2010) Alcohol dehydrogenase accentuates ethanol-induced myocardial dysfunction and mitochondrial damage in mice: role of mitochondrial death pathway. PLoS One 5:e8757
16. Guo R, Scott GI, Ren J (2010) Involvement of AMPK in alcohol dehydrogenase accentuated myocardial dysfunction following acute ethanol challenge in mice. PLoS One 5:e11268
17. Hara A, Radin NS (1978) Lipid extraction of tissues with a low-toxicity solvent. Anal Biochem 90:420-426
18. Hara A, Taketomi T (1987) Occurrence of sulfatide as a major glycosphingolipid in WHHL rabbit serum lipoproteins. J Biochem 102:83-92
19. Hara A, Taketomi T (1991) Characterization and changes of glycosphingolipids in the aorta of the Watanabe hereditable hyperlipidemic rabbit. J Biochem 109:904-908
20. Hara A, Kutsukake Y, Uemura K, Taketomi T (1993) Anticoagulant activity of sulfatide and its anti-thrombotic effect in rabbit. J Biochem 113:781-785
21. Hara A, Uemura K, Taketomi T (1996) Sulfatide prolongs blood-coagulation time and bleeding time by forming a complex with fibrinogen. Glycoconj J 13:187-194
22. Hu R, Li G, Kamijo Y, Aoyama T, Nakajima T, Inoue T, Node K, Kannagi R, Kyogashima M, Hara A (2007) Serum sulfatides as a novel biomarker for cardiovascular disease in patients with end-stage renal failure. Glycoconj J 24:565-571
23. Ishizuka I (1997) Chemistry and functional distribution of sulfoglycolipids. Prog Lipid Res 36:245-319
24. Kloner RA, Rezkalla SH (2007) To drink or not to drink? That is the question. Circulation 116:1306-1317
25. Kyogashima M (2004) The role of sulfatide in thrombogenesis and haemostasis. Arch Biochem Biophys 426:157-162
26. Lakshman R, Garige M, Gong M, Leckey L, Varatharajalu R, Zakhari S (2010) Is alcohol beneficial or harmful for cardioprotection? Genes Nutr 5:111-120
27. Li G, Hu R, Kamijo Y, Nakajima T, Aoyama T, Inoue T, Node K, Kannagi R, Kyogashima M, Hara A (2007) Establishment of a quantitative, qualitative and high throughput analysis of sulfatides from small amounts of sera by MALDI-TOF MS. Anal Biochem 362:1-7
28. Lin Y, Kikuchi S, Tamakoshi A, Wakai K, Kawamura T, Iso H, Ogimoto I, Yagyu K, Obata Y, Ishibashi T (2005) Alcohol consumption and mortality among middle-aged and elderly Japanese men and women. Ann Epidemiol 15:590-597
29. Ma H, Li J, Gao F, Ren J (2009) Aldehyde dehydrogenase 2 ameliorates acute cardiac toxicity of ethanol. J Am Coll Cardiol 54:2187-2196
30. Malcolm RD, Alkana RL (1981) Temperature dependence of ethanol depression in mice. J Pharmacol Exp Ther 217:770-775
31. Matsubara T, Tanaka N, Patterson AD, Cho JY, Krausz KW, Gonzalez FJ (2011) Lithocholic acid disrupts phospholipid and sphingolipid homeostasis leading to cholestasis in mice. Hepatology 53:1282-1293
32. Matsubara T, Tanaka N, Krausz KW, Manna SK, Kang DW, Anderson ER, Luecke H, Patterson AD, Shah YM, Gonzalez FJ (2012) Metabolomics identifies an inflammatory cascade involved in dioxin- and diet-induced steatohepatitis. Cell Metab 16:634-644
33. Motohashi H, Yamamoto M (2004) Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 10:549-557
34. Nakajima T, Kamijo Y, Tanaka N, Sugiyama E, Tanaka E, Kiyosawa K, Fukushima Y, Peters JM, Gonzalez FJ, Aoyama T (2004) Peroxisome proliferator-activated receptor α protects against alcohol-induced liver damage. Hepatology 40:972-980
35. Okamoto A, Iwamoto Y, Maru Y (2006) Oxidative stress-responsive transcription factor ATF3 potentially mediates diabetic angiopathy. Mol Cell Biol 26:1087-1097
36. Okiyama W, Tanaka N, Nakajima T, Tanaka E, Kiyosawa K, Gonzalez FJ, Aoyama T (2009) Polyenephosphatidylcholine prevents alcoholic liver disease in PPARα-null mice through attenuation of increases in oxidative stress. J Hepatol 50:1236-1246
37. Paunio M, Virtamo J, Gref CG, Heinonen OP (1996) Serum high density lipoprotein cholesterol, alcohol, and coronary mortality in male smokers. BMJ 312:1200-1203
38. Peters JM, Hennuyer N, Staels B, Fruchart JC, Fievet C, Gonzalez FJ, Auwerx J (1997) Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice. J Biol Chem 272:27307-27312
39. Ravassa S, Bennaghmouch A, Kenis H, Lindhout T, Hackeng T, Narula J, Hofstra L, Reutelingsperger C (2005) Annexin A5 down-regulates surface expression of tissue factor: a novel mechanism of regulating the membrane receptor repertoire. J Biol Chem 280:6028-6035
40. Sesso HD (2001) Alcohol and cardiovascular health: recent findings. Am J Cardiovasc Drugs 1:167-172
41. Sheng X, Nakajima T, Wang L, Zhang X, Kamijo Y, Takahashi K, Tanaka N, Sugiyama E, Kyogashima M, Aoyama T, Hara A (2012) Attenuation of kidney injuries maintains serum sulfatide levels dependent on hepatic synthetic ability: a possible involvement of oxidative stress. Tohoku J Exp Med 227:1-12
42. Tanaka N, Moriya K, Kiyosawa K, Koike K, Gonzalez FJ, Aoyama T (2008a) PPARα activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice. J Clin Invest 118:683-694
43. Tanaka N, Moriya K, Kiyosawa K, Koike K, Aoyama T (2008b) Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor α in transgenic mice: implications for HCV-associated hepatocarcinogenesis. Int J Cancer 122:124-131
44. Tanaka N, Sano K, Horiuchi A, Tanaka E, Kiyosawa K, Aoyama T (2008c) Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol 42:413-418
45. Tanaka N, Zhang X, Sugiyama E, Kono H, Horiuchi A, Nakajima T, Kanbe H, Tanaka E, Gonzalez FJ, Aoyama T (2010) Eicosapentaenoic acid improves hepatic steatosis independent of PPARα activation through inhibition of SREBP-1 maturation in mice. Biochem Pharmacol 80:1601-1612
46. Tanaka N, Matsubara T, Krausz KW, Patterson AD, Gonzalez FJ (2012) Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis. Hepatology 56:118-129
47. Tsuchiya M, Ji C, Kosyk O, Shymonyak S, Melnyk S, Kono H, Tryndyak V, Muskhelishvili L, Pogribny IP, Kaplowitz N, Rusyn I (2012) Interstrain differences in liver injury and one-carbon metabolism in alcohol-fed mice. Hepatology 56:130-139
48. Vasiliou V, Ziegler TL, Bludeau P, Petersen DR, Gonzalez FJ, Deitrich RA (2006) CYP2E1 and catalase influence ethanol sensitivity in the central nervous system. Pharmacogenet Genomics 16:51-58
49. Vatsyayan R, Kothari H, Pendurthi UR, Rao LV (2013) 4-Hydroxy-2-nonenal enhances tissue factor activity in human monocytic cells via p38 mitogen-activated protein kinase activation-dependent phosphatidylserine exposure. Arterioscler Thromb Vasc Biol 33:1601-1611
50. Walker JE, Odden AR, Jeyaseelan S, Zhang P, Bagby GJ, Nelson S, Happel KI (2009) Ethanol exposure impairs LPS-induced pulmonary LIX expression: alveolar epithelial cell dysfunction as a consequence of acute intoxication. Alcohol Clin Exp Res 33:357-365
51. Wang L, Kamijo Y, Matsumoto A, Nakajima T, Higuchi M, Kannagi R, Kyogashima M, Aoyama T, Hara A (2011) Kidney transplantation recovers the reduction level of serum sulfatide in ESRD patient via processes correlated to oxidative stress and platelet count. Glycoconj J 28:125-135
52. Xiaowei Z, Nakajima T, Kamijo Y, Li G, Hu R, Kannagi R, Kyogashima M, Aoyama T, Hara A (2009) Acute kidney injury induced by protein-overload nephropathy down-regulates gene expression of hepatic cerebroside sulfotransferase in mice, resulting in reduction of liver and serum sulfatides. Biochem Biophys Res Commun 390:1382-1388
53. Zhou Z, Wang L, Song Z, Lambert JC, McClain CJ, Kang YJ (2003) A critical involvement of oxidative stress in acute alcohol-induced hepatic TNFα production. Am J Pathol 163:1137-1146